The Children’s Clinic, Serving Children and Their Families

Slides:



Advertisements
Similar presentations
Pharmacology and the Nursing Process in LPN Practice
Advertisements

Tuberculosis Control in Substance Abuse Treatment Centers
Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.
Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
ISTC Training Modules 2008 Your name Institution/organization Meeting Date.
TB Disease and Latent TB Infection
Chattanooga-Hamilton County Epidemiology Department.
PDA is OK ….. Public/Private Doctor Agreement in Managing TB Cases Sandra Guerra-Cantu, MD, MPH Region 8 Medical Director.
Immunization and RSV/Palivizumab Clinic Update Advances in preventative care for our pediatric population.
A typical day in the TB clinic You see the following patients in the TB clinic. All have normal CXRs: 1. A 35 year old man from Hartford with a 16 mm positive.
Tuberculosis 101 JAMES R. GINDER, MS, WEMT,PI, CHES
National Tuberculosis Controllers Association
MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5.
Updated School TB Screening Policy Frank Alvarez, MD, MPH and Pamina Bagchi, MPH Los Angeles County Department of Public Health Tuberculosis Control Program.
TUBERCULOSIS. What is Tuberculosis? Tuberculosis (TB) is an infectious disease caused by the bacterium: “Mycobacterium tuberculosis”
Tuberculosis in Children: Prevention Module 10C - March 2010.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Case discussion Michael Gardam University Health Network.
TB Presentation for Healthcare Students
OSHA Blood Borne Pathogen and Tuberculosis Training PART II Tuberculosis Author: Maxine Edwards, RN, ICP ECU Infection Control Presented by: Patti Goetz,
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
TB. Areas of Concern TB cases continue to be reported in every state Drug-resistant cases reported in almost every state Estimated million persons.
Why do we test? 1.We want to prevent an outbreak of Tuberculosis in our campus community 2.We want to find those that are affected and get them treated.
Diagnosis of TB.
Tuberculosis (TB) Facts
Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.
What Drug Treatment Centers Can do to Prevent Tuberculosis
4/25/2014 Mantoux Skin Testing Joan E. McMahon, RN, MPH Tuberculosis Educator Breathe Pennsylvania.
Understanding and Preventing Tuberculosis Health, healing and hope.
* TB is caused by a bacterium called Mycobacterium Tuberculosis. The bacteria usually attacks the lungs, but TB bacteria can attack any part of the.
Tuberculosis Presented by Vivian Pham and Vivian Nguyen.
Unit 5: IPT Isoniazid TB Preventive Therapy
Allen Kraut, MD, FRCPC Medical Director, Occupational Health WRHA
TB 101: TB Basics and Global Approaches. Objectives Review basic TB facts. Define common TB terms. Describe key global TB prevention and care strategies.
Assessment of Tuberculosis Risk in Family Care Clinic Christopher Gordon, M.D. Kris Lee, M.D. RCRMC – Moreno Valley, CA.
Update on Tuberculosis contact investigation
Use of 12 weekly doses of isoniazid and rifapentine for the treatment of latent tuberculosis − Connecticut , Kelley Bemis, MPH CDC/CSTE Applied.
Rangel PDSA TB Didactic TB or not TB?. AIM Statement In order to improve care at the Charles Rangel Clinic, we will implement a tuberculosis screening.
Tuberculosis Research of INA-RESPOND on Drug-resistant
Tuberculosis Egan’s Chapter 22. Mosby items and derived items © 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2 Tuberculosis (TB) The incidence of.
Tuberculosis What is tuberculosis?.
Tuberculosis The evolution of a bacterium. 2 World Health Organization (WH.O. declared TB a global health emergency in cases per 100,
Screening for TB.
بسم الله الرحمن الرحيم. A 25 year old Saudi male applied to work as paramedic. He has no symptoms or history of contact with sick patients. His physical.
HIV/TB – Case Studies David Schlossberg, MD, FACP Medical Director, TB Control Program Philadelphia Department of Health.
TUBERCULOSIS Education Class. TB Information TB (Tuberculosis) is a chronic, communicable disease caused by the TB bacterium: “Mycobacterium tuberculosis”
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
A Self Study Powerpoint
The Epidemiology of Tuberculosis Lex Gibson, Virginia TB Program.
Tuberculosis August 17, 2010 Tuberculosis Mycobacterium tuberculosis – Fastidious, aerobic, acid-fast bacillus Tremendous increase in incidence over.
Tuberculosis By Fion Kung. Objective  Describe tuberculosis  Describe sigh and symptoms of tuberculosis  Describe the nursing diagnosis for tuberculosis.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
Tuberculosis in Children and Young Adults
Roundtable. Detection and treatment of TB Andrew Black.
Case Discussion 2 - TB IN CHILDREN by Dr. Jeyaseelan P. Nachiappan & Dr. Suryati Adnan 1 Picture of CPG Cover.
Assessment of Tuberculosis Risk in Family Care Clinic
Transmission and Pathogenesis
TB Disease and Infection
Management of the Newborn When Maternal TB Suspected
Infant born with mother Tuberculosis
This is an archived document.
Treatment of Latent TB Infection (LTBI)
The Respiratory System
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
بسم الله الرحمن الرحيم.
Tb: Screening & Diagnosis (1)
5th edition NTP MANUAL OF PROCEDURES Case Finding
Presentation transcript:

The Children’s Clinic, Serving Children and Their Families Tuberculosis Screening and Treatment at TCC Patricia Bellas, MD Associate Medical Director May 6, 2010

The Children’s Clinic, Serving Children and Their Families Who are We? TCC is an independent not-for-profit 501 (c) (3) community health center with six sites dedicated to providing comprehensive health care, health promotion and disease prevention in a culturally sensitive and linguistically appropriate manner to medically underserved, low income and high-risk populations in the Long Beach area. Our largest site is on the Long Beach Memorial Medical Center/Miller Children’s Hospital campus.

The Children’s Clinic, Serving Children and Their Families Mission Statement To partner with parents and the community to provide quality health care services, health education and promotion to needy children and families

The Children’s Clinic, Serving Children and Their Families Facts Founded in 1939 Six clinic sites In 2009: Provided over 65,746 Health Care Visits to 22,047 children and adults Lion’s Eye Clinic- provided over 1,100 comprehensive ophthalmologic visits Almost 29,000 medication provided through our dispensaries Over 19,000 immunizations provided, and a Walk-In Immunization Clinic No one is denied care due to inability to pay

The Children’s Clinic, Serving Children and Their Families TST Data At Vasek Polak Site in 2009: Total of 584 TSTs done (79% children, 21% adults) 21% did not return for readings Overall 11% positive (22% in adults, 7% in children) 5

The Children’s Clinic, Serving Children and Their Families Clinic Sites

The Children’s Clinic, Serving Children and Their Families Documents to Be Covered Today: Tuberculosis Screening Guidelines from TCC’s Clinical Policies and Procedures Tuberculosis Risk Assessment TB Patient Discharge Status Card TCC TB Patient Education Trifold (English/Spanish)

The Children’s Clinic, Serving Children and Their Families POLICIES AND PROCEDURES   SUBJECT:  TUBERCULOSIS SCREENING GUIDELINES AUTHORITY: Long Beach Department of Health and Human Services, TB Controller; Children’s Health and Disability Program (CHDP) Guidelines; Red Book, 26th Edition (Published by the American Academy of Pediatrics); Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection (Morbidity and Mortality Weekly Report) June, 2000

I. “TUBERCULOSIS RISK ASSESSMENT” The Children’s Clinic, Serving Children and Their Families Policies and Procedures I. “TUBERCULOSIS RISK ASSESSMENT” Perform tuberculosis risk assessment annually with routine physical exam. If risk assessment positive, place TST- unless patient has had a previous positive TST). Notes The TST is not useful in evaluating patients who have previously tested positive for tuberculosis re-exposure or reactivation All patients who have previously tested positive should be screened for symptoms of TB disease.  If present, a chest x-ray should be obtained. Immigrants who have been only screened with a CXR, should be TST tested and treated for LTBI if positive  

The Children’s Clinic, Serving Children and Their Families The Children’s Clinic- Tuberculosis Risk Assessment Date: MD/ NP Initials: Has the patient ever been tested for tuberculosis in the past?        Yes / No Was it Positive? Was it treated with medicine? Has the patient had chronic cough, coughing up blood, unexplained fever, weight loss or sweating at night?       Has the patient had close contact with anyone who is sick with tuberculosis? (e.g. coughing, wt loss, etc) Has the patient lived in Asia, Mexico/Latin America, Africa or the Middle East in the past 3-5 years? Does the patient spend significant time in a household with anyone who has the following: HIV/AIDS        Long term illegal drug use Recently released from prison (past year)        Recently arrived from another country – (past year) Has the patient lived in a homeless shelter in the past year?

Policies and Procedures (cont.) The Children’s Clinic, Serving Children and Their Families Policies and Procedures (cont.) II. When to do Tuberculin Skin Testing (TST): Immediate TST in children and adults: i. displaying symptoms or radiographic findings of TB. ii. contacts of those with confirmed or suspected TB. iii. Children and adults with HIV or living with HIV infected adult (if last TST>1 year ago) Annual TST on children and adults with HIV or living with HIV infected adult. TST every 2 years for children with ongoing potential exposure by risk assessment Routine screening with TST at 1 year of age, repeat TST placed at 4-6 years and 11-16 years for people without additional risk factors. BCG: Place TST no sooner than 1 year after BCG placement.

Policies and Procedures (cont.) The Children’s Clinic, Serving Children and Their Families Policies and Procedures (cont.) II. When to do Tuberculin Skin Testing (TST): Adults: no routine TST; use “TUBERCULOSIS RISK ASSESSMENT” to determine need for TST Adults at higher risk for re-activation of LTBI need to have clear documentation of TST status Diabetes mellitus, silicosis, chronic renal failure/dialysis, gastrectomy, jejunoileal bypass, solid organ transplantation, carcinoma of head or neck, etc.

Policies and Procedures (cont.) The Children’s Clinic, Serving Children and Their Families Policies and Procedures (cont.) III. Interpretation and reporting guidelines: Interpret TST according to standardized guidelines. All patients with a positive TST should be referred for CXR.  TST may be repeated at any time if patient failed TST reading. File “Confidential Morbidity Report” (CMR) for the following i. All children three years and under if positive. ii. Chest X-ray findings suggestive of TB- provider to direct Medical Assistant to file CMR in these cases. Note PPD “converters” no longer need to be reported

Policies and Procedures (cont.) The Children’s Clinic, Serving Children and Their Families Policies and Procedures (cont.) Monitoring Pediatric patients must return to clinic at least every 3 months   Adults have a higher risk of side effects and should be seen monthly or every other month LFT testing (SGOT or SGPT and Bili) is not routinely indicated LFTs are recommended in early postpartum period (within 3 months of delivery) and for HIV. 270 doses (9 months) must be administered within 1 year for treatment to be considered complete. Lapses of <3 months: restart INH where left off to complete course Lapses of >3 months: Consider a repeat chest X-ray if symptomatic or if lapse very long (e.g. 1 year) Restart INH therapy from beginning At end of INH therapy, Tuberculosis Patient Discharge Status card should be given to patient

The Children’s Clinic, Serving Children and Their Families

Policies and Procedures (cont.) The Children’s Clinic, Serving Children and Their Families Policies and Procedures (cont.) Adverse reactions/discontinuing treatment Patients who have allergic reactions to INH Liver function tests are more than 3 times normal limits Noncompliance/patient choice Severe reactions to INH will be reported to the health department for inclusion in national surveillance.

The Children’s Clinic, Serving Children and Their Families

Common Dilemmas in LTBI Treatment To Treat or Not to Treat? The Children’s Clinic, Serving Children and Their Families Common Dilemmas in LTBI Treatment To Treat or Not to Treat? “A decision to test is a decision to treat” does not necessarily apply to low-risk persons tested because mandated by law (i.e., teachers) Need to assess patient’s beliefs, concerns and motivation regarding LTBI Rx, and have an individualized risk-benefit discussion Not-so-clear cases: 30 y.o. Hispanic woman with hx +TST at age 20, no Rx, no known risk factors 43 y.o. Hispanic woman tested +TST (not documented) during pregnancy, no Rx, now with diabetes 52 y.o. man with former heavy EtOH, hx +TST, started but did not finish LTBI Rx 12 y.o. US born student with no TB risk factors with 11 mm TST upon entry to new school; last TST in kindergarten negative

The Children’s Clinic, Serving Children and Their Families Other LTBI Rx Dilemmas Patients who report prior +TST (without documentation) with indication for Rx… Repeat TST or not? Patients with ill-defined (“just don’t feel good”) symptoms on INH, but normal LFTs and nothing on exam… Continue or hold INH? Different approach if higher risk for TB disease? When do you check an IGRA, and what do you do with discordant results?

The Children’s Clinic, Serving Children and Their Families Case #1 66 y.o. Cambodian female with diabetes, first seen in clinic 12/08 and sent to hospital with pneumonia PPD was positive, but also had high LFTS 444 - neg AFB and culture Pneumonia resolved (f/u CXR 2 months later normal) LFTs returned to almost normal, but patient very frail and noted to have Hep C; difficult social situation and awaiting hepatic consult Presented again several months later with URI sxs, then worsening respiratory sx; sent back to hosp to R/O TB Now upper lobe process; CT in hosp showed some cavitary lesion, but no caseating granuloma on path Had lung wedge resection - neg AFB smear, but after discharge sputum grew out TB

The Children’s Clinic, Serving Children and Their Families Case #2 44 y/o Mexican immigrant in US many years but travels back and forth to visit extended family in Mexico, no hx TST Came for PE; based on TB risk assessment (freq travel to Mexico), PPD placed and was + CXR neg - LFTS tested and were WNL No other risks - started INH - seen at month 1 then month 3, then month 6 (called for refill on meds) - hard to come in At month 6 visit c/o 2 weeks of fatigue, malaise and dark urine (did not stop meds): LFTS 1300s: meds stopped.   Work up neg for viral hep (turns out he drinks some- although he says not heavy) LFTs gradually resolved over the year, however still has splenomegaly and stable but reduced platelets suggestive of hypersplenism

The Children’s Clinic, Serving Children and Their Families Thank you! Any questions? Contact: Patty Bellas pbellas@thechildrensclinic.org